Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser + Triamcinolone in HS
NCT05580029Phase 1Unknown
- Sponsor
- University of Southern California
- Start
- Nov 2022
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label, single-arm trial of triamcinolone acetonide in hidradenitis suppurativa (HS), sponsored by University of Southern California. Primary endpoints: Endpoint Measure of non-inflammatory nodules, Endpoint measure of Fibrometer measurements and 12 more. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT05580029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05580029.